Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

IRE1/XBP-1 activation has a major role in Triple negative breast cancer (TNBC). Here, the authors show that inhibition of IRE1’s RNase activity attenuates autocrine and paracrine signaling of pro-tumorigenic cytokines and synergizes with paclitaxel to confer potent anti-tumor effects in TNBC.

Guardado en:
Detalles Bibliográficos
Autores principales: Susan E. Logue, Eoghan P. McGrath, Patricia Cleary, Stephanie Greene, Katarzyna Mnich, Aitor Almanza, Eric Chevet, Róisín M. Dwyer, Anup Oommen, Patrick Legembre, Florence Godey, Emma C. Madden, Brian Leuzzi, Joanna Obacz, Qingping Zeng, John B. Patterson, Richard Jäger, Adrienne M. Gorman, Afshin Samali
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/397f4e630bac42c587fdf199a5689e3f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:397f4e630bac42c587fdf199a5689e3f
record_format dspace
spelling oai:doaj.org-article:397f4e630bac42c587fdf199a5689e3f2021-12-02T15:33:43ZInhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy10.1038/s41467-018-05763-82041-1723https://doaj.org/article/397f4e630bac42c587fdf199a5689e3f2018-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05763-8https://doaj.org/toc/2041-1723IRE1/XBP-1 activation has a major role in Triple negative breast cancer (TNBC). Here, the authors show that inhibition of IRE1’s RNase activity attenuates autocrine and paracrine signaling of pro-tumorigenic cytokines and synergizes with paclitaxel to confer potent anti-tumor effects in TNBC.Susan E. LogueEoghan P. McGrathPatricia ClearyStephanie GreeneKatarzyna MnichAitor AlmanzaEric ChevetRóisín M. DwyerAnup OommenPatrick LegembreFlorence GodeyEmma C. MaddenBrian LeuzziJoanna ObaczQingping ZengJohn B. PattersonRichard JägerAdrienne M. GormanAfshin SamaliNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Susan E. Logue
Eoghan P. McGrath
Patricia Cleary
Stephanie Greene
Katarzyna Mnich
Aitor Almanza
Eric Chevet
Róisín M. Dwyer
Anup Oommen
Patrick Legembre
Florence Godey
Emma C. Madden
Brian Leuzzi
Joanna Obacz
Qingping Zeng
John B. Patterson
Richard Jäger
Adrienne M. Gorman
Afshin Samali
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
description IRE1/XBP-1 activation has a major role in Triple negative breast cancer (TNBC). Here, the authors show that inhibition of IRE1’s RNase activity attenuates autocrine and paracrine signaling of pro-tumorigenic cytokines and synergizes with paclitaxel to confer potent anti-tumor effects in TNBC.
format article
author Susan E. Logue
Eoghan P. McGrath
Patricia Cleary
Stephanie Greene
Katarzyna Mnich
Aitor Almanza
Eric Chevet
Róisín M. Dwyer
Anup Oommen
Patrick Legembre
Florence Godey
Emma C. Madden
Brian Leuzzi
Joanna Obacz
Qingping Zeng
John B. Patterson
Richard Jäger
Adrienne M. Gorman
Afshin Samali
author_facet Susan E. Logue
Eoghan P. McGrath
Patricia Cleary
Stephanie Greene
Katarzyna Mnich
Aitor Almanza
Eric Chevet
Róisín M. Dwyer
Anup Oommen
Patrick Legembre
Florence Godey
Emma C. Madden
Brian Leuzzi
Joanna Obacz
Qingping Zeng
John B. Patterson
Richard Jäger
Adrienne M. Gorman
Afshin Samali
author_sort Susan E. Logue
title Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
title_short Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
title_full Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
title_fullStr Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
title_full_unstemmed Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
title_sort inhibition of ire1 rnase activity modulates the tumor cell secretome and enhances response to chemotherapy
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/397f4e630bac42c587fdf199a5689e3f
work_keys_str_mv AT susanelogue inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT eoghanpmcgrath inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT patriciacleary inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT stephaniegreene inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT katarzynamnich inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT aitoralmanza inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT ericchevet inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT roisinmdwyer inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT anupoommen inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT patricklegembre inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT florencegodey inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT emmacmadden inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT brianleuzzi inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT joannaobacz inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT qingpingzeng inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT johnbpatterson inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT richardjager inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT adriennemgorman inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
AT afshinsamali inhibitionofire1rnaseactivitymodulatesthetumorcellsecretomeandenhancesresponsetochemotherapy
_version_ 1718387016782053376